General Information of DTT (ID: TTIW59R)

DTT Name C-X-C chemokine receptor type 5 (CXCR5) DTT Info
Gene Name CXCR5

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Clinical Trial Drug(s)
Preclinical Drug(s)
2 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
PF-06835375 DMNIYPS Immune thrombocytopenic purpura 3B64.13 Phase 2 [1]
SAR113244 DMRIH0S Systemic lupus erythematosus 4A40.0 Phase 1 [2]
------------------------------------------------------------------------------------
1 Preclinical Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
JT08 DM8OAZ6 Solid tumour/cancer 2A00-2F9Z Preclinical [3]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 ClinicalTrials.gov (NCT05070845) AN INTERVENTIONAL PHASE 2, OPEN-LABEL, MULTI-CENTER STUDY TO EVALUATE SAFETY AND EFFICACY OF PF-06835375 IN ADULT PARTICIPANTS WITH MODERATE TO SEVERE PRIMARY IMMUNE THROMBOCYTOPENIA. U.S.National Institutes of Health.
2 Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.
3 Clinical pipeline report, company report or official report of Jyant Technologies.